Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gout drug developer Ardea reports bigger 3Q loss
Yahoo/AP
Friday, November 4, 2011 - 12:17pm
tags:
Ardea, earnings, gout
Seattle Genetics beats Wall Street predictions for new cancer drug
Bizjournals.com
Friday, November 4, 2011 - 9:31am
tags:
Seattle Genetics, earnings
Inhibitex Soars as Investors See Another Pharmasset in the Making
TheStreet.com
Friday, November 4, 2011 - 9:29am
tags:
Inhibitex, Pharmasset, INX-189, hepatitis C, PSI-7977
Allergan Says Massachusetts AG Wants Documents on Group
Bloomberg
Friday, November 4, 2011 - 9:28am
tags:
Allergan, Massachusetts
Vivus says FDA accepts weight-loss drug application
Reuters
Friday, November 4, 2011 - 9:24am
tags:
FDA, obesity, Vivus, Qnexa
Cornerstone Therapeutics 3Q profit slips
Yahoo/AP
Friday, November 4, 2011 - 9:23am
tags:
earnings, Cornerstone Therapeutics
Alimera Sciences Reports Third Quarter 2011 Financial Results
Yahoo
Friday, November 4, 2011 - 9:22am
tags:
earnings, Alimera
Becton Valued Like It’s 1993 Invites Medical Takeovers: Real M&A
Bloomberg
Friday, November 4, 2011 - 9:21am
tags:
M&A, Becton Dickinson, JNJ
Oxigene Headed Back Down On Disappointing Zybrestat Results
Seeking Alpha
Friday, November 4, 2011 - 9:20am
tags:
Zybrestat, Oxigene, non-small cell lung cancer
5 Healthcare Stocks With Impressive Profitability Trading Near Highs
Seeking Alpha
Friday, November 4, 2011 - 9:19am
tags:
Allergan, GSK, JNJ, Eli Lilly, Medicis
Amgen Is A Bargain At These Levels
Seeking Alpha
Thursday, November 3, 2011 - 12:33pm
tags:
Amgen
Speculative Biotech: A Speculation Trader's Dream and Nightmare
Seeking Alpha
Thursday, November 3, 2011 - 12:24pm
tags:
MannKind, Transcept, BioMimetic Therapeutics
Medivation rockets 120% on drug study
Marketwatch
Thursday, November 3, 2011 - 12:21pm
tags:
Medivation, prostate cancer, MDV3100
Pozen narrows 3Q net loss
Bizjournals.com
Thursday, November 3, 2011 - 12:20pm
tags:
earnings, Pozen
P&G raises profit outlook on Teva JV, Pringles sale
Yahoo/AP
Thursday, November 3, 2011 - 12:19pm
tags:
Teva Pharmaceuticals, P&G, guidance
Dendreon beaten down again on so-so Provenge sales update
Fierce Pharma
Thursday, November 3, 2011 - 11:37am
tags:
Dendreon, Provenge, prostate cancern
FDA Touts Pace of Its Drug Approvals Over European Counterparts
Bloomberg
Thursday, November 3, 2011 - 11:35am
tags:
FDA, drug approvals, Europe
Will Bristol-Myers Squibb Earn or Burn?
Motley Fool
Thursday, November 3, 2011 - 11:35am
tags:
Bristol-Myers Squibb, Teva Pharmaceuticals, Pfizer, Watson
Novo Nordisk Rejects China M&A; Plans Growth Through Innovation
Seeking Alpha
Thursday, November 3, 2011 - 10:59am
tags:
China, innovation, Novo Nordisk
Sanofi Profit Declines 3%, Hurt by Generic Competition
Bloomberg
Thursday, November 3, 2011 - 8:53am
tags:
Sanofi, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.